Search results
Is It Too Late to Buy Novavax Stock?
The Motley Fool via AOL· 4 days agoIt probably is too late to invest in Novavax's stock, because this rally may not end up holding up for the rest of the year. ...stock remains significantly ...
XML Financial LLC Sells 5,445 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 7 days agoXML Financial LLC trimmed its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 54.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor ...
Biotech With 345% Run Posts A 'Clear Win' In Cancer Treatment
Investor's Business Daily· 2 hours agoThe company tested its treatment, dubbed NX-5948, in patients with relapsed or refractory forms of...
Sarepta Jumps After Rival Gene Therapy From Pfizer Flops
Investor's Business Daily· 4 days agoThe news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with the muscle-wasting ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 6 hours agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Charles River (CRL) Partners to Reduce Animal Research Usage
Zacks via Yahoo Finance· 6 days agoPrice Performance Over the past year, Charles River shares have risen 4...Zacks Rank #1 (Strong...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks· 4 days agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop FG-M701, a next-generation TL1A antibody, for IBD indications.
